ask="9.05"
ask_size="1000"
average_daily_volume="1806710"
bid="8.55"
bid_size="300"
book_value="0.02"
change="-0.28"
change_from_200_day_moving_average="3.09"
change_from_50_day_moving_average="2.07"
change_from_52_week_high="-0.50"
change_From_52_week_low="6.24"
change_in_percent="-3.15%"
close="8.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.75"
ebitda="-48.12M"
eps_estimate_current_year="-0.68"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.66"
ex_dividend_date="N/A"
float_shares="50464000"
high="9.01"
high_52_weeks="9.10"
last_trade_date="3/13/2017"
last_trade_price="8.60"
last_trade_size="68283"
last_trade_time="4:00pm"
low="8.40"
low_52_weeks="2.36"
market_capitalization="636.01M"
moving_average_200_day="5.51"
moving_average_50_day="6.53"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.78"
open="8.88"
pe_ratio="N/A"
peg_ratio="-0.65"
percent_change_from_200_day_moving_average="+56.11%"
percent_change_from_50_day_moving_average="+31.80%"
percent_change_from_52_week_high="-5.49%"
percent_change_from_52_week_low="+264.41%"
previous_close="8.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="422.86"
price_per_sales="24.92"
revenue="26.35M"
shares_outstanding="73955000"
short_ratio="10.66"
stock_exchange="NMS"
symbol="BCRX"
volume="2361279"
weeks_range_52="2.36 - 9.10"
